Home

The main activities of PharmaDiall is the search, development, chemical synthesis, in vitro testing, animal testing (prior to clinical trials), organization of clinical trials (1st and 2nd phases) and patenting of new biologically active chemicals capable of turning into medicines in the future.

News

Acquisition of patent in the USA

Acquisition of patent in the USA

In the USA, a decision to issue a patent on application No. 13/599.038 was taken. This is a patent for substance DD217 and related compounds - “Urethanes, ureas, amides and related scale preventers of Xa factor".